Supplementary Table S3. Agreement between three biomarker IHC-based and intrinsic subtypes: impact of adding tumor grade to distinguish between luminal A and luminal B cases. from Performance of Three-Biomarker Immunohistochemistry for Intrinsic Breast Cancer Subtyping in the AMBER Consortium
Year: 2023
Type: supplementary-materials
Abstract: Agreement between IHC-based and RNA-based intrinsic subtyping using tumor grade in addition to ER, PR and HER2 expression
Authors: Emma H. Allott, Stephanie M. Cohen, Joseph Geradts, Xuezheng Sun, Thaer Khoury, Wiam Bshara, Gary R. Zirpoli, C. Ryan Miller, Helena Hwang, Leigh B. Thorne, Siobhan O'Connor, Chiu-Kit Tse, Mary B. Bell, Zhiyuan Hu, Yan Li, Erin L. Kirk, Traci N. Bethea, Charles M. Perou, Julie R. Palmer, Christine B. Ambrosone, Andrew F. Olshan, Melissa A. Troester
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: gold
OpenAlex ID: W4362425285